Posted by JohnX on March 12, 2001, at 5:07:39
In reply to Who was asking about CRF antagonists, posted by vince on March 12, 2001, at 0:00:59
> There have been one or two posts lately asking about cortisol blockers or CRF antagonists. The following press release might be of some interest to you.
>
> Vince
>
> http://psychiatry.medscape.com/reuters/prof/2001/03/03.09/20010308drgd008.html
> --------------------------------------------------------------------------------
> Phase I Data Positive on CRF Receptor Antagonist for Depression, Anxiety
> --------------------------------------------------------------------------------
>
> NEW YORK (Reuters Health) Mar 08 - Neurocrine Biosciences, of San Diego, said on Thursday that data from a phase I trial of its corticotropin releasing factor (CRF) receptor antagonist product for depression and anxiety indicate that the drug is well tolerated.
>
> According to Neurocrine, the company believes that the drug blocks stress responses mediated by CRF, resulting in anti-anxiety and anti-depressant effects.
>
> Additionally, the 48-patient single-dose study indicated rapid absorption, as well as good dose-proportionality and plasma half-lives of the CRF receptor antagonist that support a once-daily dosing schedule.
>
> A 2-week, multi-dose, dose-escalating trial is planned to evaluate the safety and endocrine profiles of the compound, the company said. Phase II trials are expected to follow.Hey that's good news. When would one expect a CRF-antagonist to potentially hit the market?
I hope these treatments also show promise especially for PTSD patients where dysfunction in the HPA axis is hoped to the best place to target for 1st line treatment.
-john
poster:JohnX
thread:56265
URL: http://www.dr-bob.org/babble/20010310/msgs/56270.html